VISTA: A Promising Target for Cancer Immunotherapy?
Marco Tagliamento,1,2 Elisa Agostinetto,3,4 Roberto Borea,2,5 Mariana Brandão,3 Francesca Poggio,6 Alfredo Addeo,7 Matteo Lambertini2,8 1Department of Medical Oncology, Medical Oncology 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medicine and Medical...
Main Authors: | Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-06-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/vista-a-promising-target-for-cancer-immunotherapy-peer-reviewed-fulltext-article-ITT |
Similar Items
-
Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby
by: Ji-Eun Irene Yum, et al.
Published: (2021-04-01) -
VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
by: Xing Huang, et al.
Published: (2020-06-01) -
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
by: Negar Hosseinkhani, et al.
Published: (2021-05-01) -
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
by: Muhammad Umair Mushtaq, et al.
Published: (2018-07-01) -
Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
by: Emmanouil Damilakis, et al.
Published: (2020-04-01)